Estrella Immunopharma (Estrella Immunopharma) Gross-Profit-to-Asset % : 0.00% (As of Mar. 2024)

Estrella Immunopharma Gross-Profit-to-Asset % Chart

Estrella Immunopharma Quarterly Data
	Jun21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Sep23	Dec23	Mar24
Gross-Profit-to-Asset %	Get a 7-Day Free Trial					-	-	-	-	-

Competitive Comparison of Estrella Immunopharma's Gross-Profit-to-Asset %

For the Biotechnology subindustry, Estrella Immunopharma's Gross-Profit-to-Asset %, along with its competitors' market caps and Gross-Profit-to-Asset % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Estrella Immunopharma's Gross-Profit-to-Asset % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Estrella Immunopharma's Gross-Profit-to-Asset % distribution charts can be found below:

* The bar in red indicates where Estrella Immunopharma's Gross-Profit-to-Asset % falls into.

Estrella Immunopharma Gross-Profit-to-Asset % Calculation

Estrella Immunopharma's annualized Gross-Profit-to-Asset % for the fiscal year that ended in Jun. 2021 is calculated as:

Estrella Immunopharma's annualized Gross-Profit-to-Asset % for the quarter that ended in Mar. 2024 is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual Gross-Profit-to-Asset %, the Gross Profit of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Gross Profit data used here is four times the quarterly (Mar. 2024) data. Gross-Profit-to-Asset % is displayed in the 30-year financial page.

Estrella Immunopharma Gross-Profit-to-Asset % Related Terms

Thank you for viewing the detailed overview of Estrella Immunopharma's Gross-Profit-to-Asset % provided by GuruFocus.com. Please click on the following links to see related term pages.

Estrella Immunopharma (Estrella Immunopharma) Business Description